ClearPoint Neuro(CLPT) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Business Outlook The Company reaffirms its full year 2025 revenue outlook between $36.0 million and$41.0 million. Financial Results – Quarter Ended March 31, 2025 ClearPoint Neuro Reports First Quarter 2025 Results Record Revenue Highlighted by 70% Growth in Single-Use Navigation and Therapy Products SOLANA BEACH, CA, May 13, 2025 – ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, ...